Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addictive Threshold of Nicotine
NCT06096714Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Feb 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of nicotine (2 arms), sponsored by Yale University. Primary endpoint: Percentage of correctly identified nicotine and saline infusions at 8 weeks. Started Feb 2024; status: recruiting.
02
Drugs
nicotine
Beyond the preview
Go deeper on NCT06096714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06096714.